Zoek een onderzoeksproject
Andere zoekoptie(s)
121 Resultaat/Resultaten
Gefinancierd door een IRDiRC-lid = Member of a ERN =
Onderzoeksprojecten

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
STEM-HD: technological resources for mass cell production and culture of hES in Huntington's disease
European Commission
DG Research - Directorate General for Research

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EUROWILSON: European network on Wilson disease (coordination)
European Commission
DG Research - Directorate General for Research

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EUROCARE CF: European coordination action for research in cystic fibrosis (coordination)
European Commission
DG Research - Directorate General for Research

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
TREAT-NMD: Accelerating Treatments for Neuromuscular Diseases (coordination)
European Commission
DG Research - Directorate General for Research

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
NEUPROCF: new diagnostic and prognostic biomarkers in cystic fibrosis (coordination)
European Commission
DG Research - Directorate General for Research

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
STEM-HD: embryonic stem cells for therapy and exploration of mechanisms in Huntington disease (coordination)
European Commission
DG Research - Directorate General for Research

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
ANTIMAL: development of new drugs for the treatment of malaria (coordination)
European Commission
DG Research - Directorate General for Research

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
CONTICANET: Connective Tissue Cancers Network (coordination)
European Commission
DG Research - Directorate General for Research

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
NEUROPRION: European network dedicated to research on prion diseases (coordination)
European Commission
DG Research - Directorate General for Research
Multicentrische onderzoeksprojecten
- Prins Leopold Instituut voor Tropische Geneeskunde (ITG)
- Department of molecular parasitology
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- European Commission
- DG Research - Directorate General for Research
- Université de Liège
- Centre d'Immunologie de Liège
- The Cyprus Institute of Neurology and Genetics
- Department of molecular genetics A
- Rigshospitalet
- Department of infectious diseases
- EVI - Universitätsklinikum Heidelberg
- European Vaccine Initiative
- EVI - Universitätsklinikum Heidelberg
- European Vaccine Initiative
- Universitätsklinikum Mannheim
- European Leukemia Net - Network Management Center
- Hertie-Institut für klinische Hirnforschung (HIH)
- Abteilung für Neurologie mit Schwerpunkt Epileptologie
- Institut für Medizinische Genetik und angewandte Genomik Tübingen
- Institut für Medizinische Genetik und angewandte Genomik
- Institut für Medizinische Genetik und angewandte Genomik Tübingen
- Institut für Medizinische Genetik und angewandte Genomik
- Zentrum Innere Medizin (ZIM)
- Medizinische Klinik und Poliklinik II
- Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
- Klinik für Innere Medizin - Schwerpunkt Gastroenterologie und Endokrinologie
- Institut für Immunologie
- Institut für Immunologie der Universitätsmedizin Rostock
- Medizinische Hochschule Hannover
- Abteilung für Virologie
- Institut für Biochemie der Universität Kiel
- Unit of Molecular Cell Biology and Transgenic Research
- University of Helsinki
- Molecular and Cancer Biology Research Unit
- Faculté de médecine de Clermont-Ferrand
- Laboratoire de Génétique, Reproduction et Développement
- Institut Albert Bonniot
- INSERM U 823 - Institut d'oncologie
- CLCC Léon Bérard
- Cancérologie médicale - Sarcomes et GIST, Tumeurs rares
- Institut de Biologie et Chimie des Protéines
- LBTI - Laboratoire de Biologie Tissulaire et Ingénierie thérapeutique
- GENOPOLE - Campus 1
- I-Stem - Institut des cellules Souches pour le Traitement et l'Etude des maladies Monogéniques
- CEA - Commissariat à l'Energie Atomique
- Service d'étude des prions et des infections atypiques
- Faculté de médecine Paris-Descartes, Site Necker
- Département "Biologie cellulaire" - Equipe "Canalopathies épitheliales: Mucoviscidose et autres maladies"
- Hôpital Necker-Enfants Malades
- Service de Génétique Moléculaire
- Institut de Myologie - Hôpital Pitié-Salpêtrière
- Equipe "Myasthenia Gravis: étiologie, physiopathologie & approche thérapeutique"
- Institut de la Vision
- Centre d'Investigation Clinique (CIC) de l'hôpital des Quinze-Vingts
- Centre de recherche Inserm
- Immunopathologie des maladies tumorales et auto-immunes
- Parc scientifique et technologiques de Luminy
- CIML - Centre d'Immunologie Marseille-Luminy
- Istituto Ortopedico Rizzoli - Centro di Ricerca e Poliambulatorio
- S.C. Laboratorio di Oncologia Sperimentale
- Centro di Riferimento Oncologico
- Unità di Bioimmunoterapia
- Istituto Dermopatico dell'Immacolata - IRCCS
- Laboratorio di Biologia Molecolare e Cellulare
- IRCCS Ospedale San Raffaele
- Centro di Genomica, Bioinformatica e Biostatistica - Unità di Genetica Umana e Molecolare
- SIENA BIOTECH SPA
- Unità di Neurobiologia
- Azienda ULSS 9 - Ospedale di Treviso
- U.O. di Neurologia
- Radboudumc - Radboud universitair medisch centrum
- Radboud Centrum voor Mitochondriële Geneeskunde
- Radboudumc - Radboud universitair medisch centrum
- Afdeling Kinderurologie
- UMCG - Universitair Medisch Centrum Groningen
- Afdeling Genetica
- AZM - Academisch Ziekenhuis Maastricht
- Laboratorium Clinical Genomics
- Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
- Groep Tumorbiologie
- LUMC - Leids Universitair Medisch Centrum
- Afdeling Pathologie
- Institution: Information not provided - AT
- Avir Green Hills Biotechnology
- Department for viral engineering
- Medizinische Universität Wien
- Center for Brain Research
- Vienna Biocenter
- Department for Medical Biochemistry of the Medical University of Vienna
- IRB Barcelona - Instituto de Investigación Biomédica
- Transportadores de aminoácidos y enfermedad
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
- Institut d'Investigacions Biomèdiques August Pi i Sunyer
- University of Bristol
- Department of Physiology and Pharmacology
- Developmental Psychiatry - University of Cambridge
- Learning Disabilities Research Group
- John van Geest Centre for Brain Repair
- NeuroNE
- Liverpool School of Tropical Medicine
- Department of Molecular Biochemical Parasitology
- The Sheffield Children's Hospital
- Sheffield Children's Hospital (Division of Child Health)
- Newcastle upon Tyne Hospitals NHS Trust
- John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine
- St James's University Hospital
- Cancer Research UK Clinical Centre, Cancer Genetics Building
- Akademiska Sjukhuset
- Department of Medical Sciences
- Uppsala Universitet
- Department of immunology, Genetics and Pathology, IGP

ANTWERPEN
ANTWERPEN
LEISHMED: Monitoring risk factors of spreading of Leishmaniasis around the Mediterranean Basin

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
MYASTAID: European network on myasthenia (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
ENRAH-SME: European network for research on alternating hemiplegia in childhood for promoting SMEs integration

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EUROSCA: European integrated project on spinocerebellar ataxias (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
GENOSTEM: adult mesenchymal stem cells for connective tissue disorders: from the bench to the bed side (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EUROWILSON: European network on Wilson disease (research)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
THERAPEUSKIN: European network on gene therapy of hereditary epidermolysis bullosa (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EUNEURONE: European Consortium for Research in Neurodegenerative Diseases

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
ITHANET: Euromediterranean network of research centres conducting molecular and clinical research of thalassaemia and related haemoglobinopathies

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EUMITOCOMBAT: rational treatment strategies combating mitochondrial oxidative phosphorylation (OXPHOS) disorders (TERMINATED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
PROTHETS: prognosis and therapeutic targets in the 'Ewing' family of tumors (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
AUTOROME: from immune responses in rare autoimmune diseases to novel therapeutic intervention strategies-a personalized medicine approach (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EUROCARE CF: European coordination action for research in cystic fibrosis

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
PWS: Prader-Willi Syndrome: a model linking gene expression, obesity and mental health

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EUGINDAT: European genomics initiative on disorders of plasma membrane amino acid transporters

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EVI-GENORET: functional genomics of the retina in health and disease (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EURAMY: systemic amyloidoses in Europe

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
MYORES: European Muscle Development Network (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EUROBONET: European bone tumors network

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
ELAST-AGE: targeting the elastic tissues ageing to improve the quality of ageing (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
GenoMEL : the Melanoma Genetics Consortium

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
GENESKIN: European network on rare genetic skin diseases

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
NEUPROCF: new diagnostic and prognostic biomarkers in cystic fibrosis (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
PNSEURONET: European network on Paraneoplastic Neurological Syndromes

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EUROPEAN LEUKEMIA NET: Strengthen and develop scientific and technological excellence in research and therapy of leukemia

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
MOLDIAG-PACA: Novel molecular diagnostic tools for the prevention and diagnosis of pancreatic cancer (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
RATSTREAM: European project on the characterisation of transgenic rat models for neurodegenerative and psychiatric diseases: Automated home cage analyses, live imaging and treatment (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
MANASP: Development of novel management strategies for invasive aspergillosis (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
HUE-MAN: Towards the development of an effective enzyme replacement therapy for human alpha- mannosidosis (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
MITOCIRCLE: mitochondrial diseases: from bedside to genome to bedside (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
ANTEPRION: development of a pre-clinical blood test for prion diseases (COMPLETED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EMVDA: the European malaria vaccine development association

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EURHAVAC: European network for harmonisation of malaria vaccine development (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EURO-LAMINOPATHIES: nuclear envelope-linked rare human diseases: from molecular pathophysiology towards clinical applications

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
ANTIMAL: development of new drugs for the treatment of malaria

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
CILMALVAC: The tetrahymena system as an innovative approach to malaria antigene expression (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
CONTICANET: Connective Tissue Cancers Network

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EPICURE: Functional genomics and neurobiology of epilepsy: a basis for new therapeutic strategies

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EURAPS: autoimmune polyendocrine syndrome type I - a rare disorder of childhood as a model for autoimmunity (TERMINATED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EUROTHYMAIDE: understanding the mechanisms underlying the development of autoimmune diseases, by exploring the major biological functions of the thymus

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
HUMALMAB: human monoclonal antibodies as tools for malaria research and therapy (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
IMMUNOPRION: strains, species and immunology in prion diseases (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
INCA : Research on the role of chronic Infections in the development of Cancer (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
LEISHMED: Monitoring risk factors of spreading of Leishmaniasis around the Mediterranean Basin

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
LYMPHANGIOGENOMICS: genome-wide discovery and functional analysis of novel genes in lymphangiogenesis (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
MALARIA AGE EXPOSURE: age of exposure and immunity to malaria in infants

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
MMR-RELATED CANCER: prevention, diagnosis and molecular characterisation of mismatch repair defect-related hereditary cancers of the digestive system

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
MPCM: pathogenic role of micro-vesiculation in cerebral malaria (FINISHED)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
NEUROPRION: European network dedicated to research on prion diseases

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
PEROXISOMES: Integrated project to decipher the biological function of peroxisomes in health and disease

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
SARS/FLU VACCINE: development of a combined Influenza/SARS vaccine

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
SPASTICMODELS: genetic models of chronic neuronal degeneration causing hereditary spastic paraplegia

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
STEM-HD: embryonic stem cells for therapy and exploration of mechanisms in Huntington disease

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
TAMAHUD: identification of early disease markers, novel pharmacologically tractable targets and small molecule phenotypic modulators in Huntington's Disease

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
TREAT-NMD: Accelerating Treatments for Neuromuscular Diseases (research)

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
VITAL: development of optimised recombinant idiotypic vaccines for subset-specific immunotherapy of B cell lymphomas

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
EUROSTEC: soft tissue engineering for congenital birth defects: New treatment modalities for spina bifida, urogenitial and abdominal wall defects (COMPLETED)

LIEGE
LIEGE
EUROTHYMAIDE: understanding the mechanisms underlying the development of autoimmune diseases, by exploring the major biological functions of the thymus

Cyprus
NICOSIA
ITHANET: Euromediterranean network of research centres conducting molecular and clinical research of thalassaemia and related haemoglobinopathies

Hovedstaden
COPENHAGEN
HUMALMAB: human monoclonal antibodies as tools for malaria research and therapy (FINISHED)

Baden-Württemberg
HEIDELBERG
EMVDA: the European malaria vaccine development association

Baden-Württemberg
HEIDELBERG
EURHAVAC: European network for harmonisation of malaria vaccine development (FINISHED)

Baden-Württemberg
MANNHEIM
EUROPEAN LEUKEMIA NET: Strengthen and develop scientific and technological excellence in research and therapy of leukemia

Baden-Württemberg
TÜBINGEN
EPICURE: Functional genomics and neurobiology of epilepsy: a basis for new therapeutic strategies

Baden-Württemberg
TÜBINGEN
EUROSCA: European integrated project on spinocerebellar ataxias (FINISHED)

Baden-Württemberg
TÜBINGEN
RATSTREAM: European project on the characterisation of transgenic rat models for neurodegenerative and psychiatric diseases: Automated home cage analyses, live imaging and treatment (FINISHED)

Bayern
WÜRZBURG
MANASP: Development of novel management strategies for invasive aspergillosis (FINISHED)

Hessen
MARBURG
MOLDIAG-PACA: Novel molecular diagnostic tools for the prevention and diagnosis of pancreatic cancer (FINISHED)

Mecklenburg-Vorpommern
ROSTOCK
AUTOROME: from immune responses in rare autoimmune diseases to novel therapeutic intervention strategies-a personalized medicine approach (FINISHED)

Niedersachsen
HANNOVER
INCA : Research on the role of chronic Infections in the development of Cancer (FINISHED)

Nordrhein-Westfalen
MÜNSTER

Schleswig-Holstein
KIEL
HUE-MAN: Towards the development of an effective enzyme replacement therapy for human alpha- mannosidosis (FINISHED)

Finland
HELSINKI
LYMPHANGIOGENOMICS: genome-wide discovery and functional analysis of novel genes in lymphangiogenesis (FINISHED)

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND
MYORES: European Muscle Development Network (FINISHED)

AUVERGNE-RHONE-ALPES
LA TRONCHE
IMMUNOPRION: strains, species and immunology in prion diseases (FINISHED)

AUVERGNE-RHONE-ALPES
LYON
CONTICANET: Connective Tissue Cancers Network

AUVERGNE-RHONE-ALPES
LYON
ELAST-AGE: targeting the elastic tissues ageing to improve the quality of ageing (FINISHED)

ILE-DE-FRANCE
EVRY
STEM-HD: embryonic stem cells for therapy and exploration of mechanisms in Huntington disease

ILE-DE-FRANCE
FONTENAY-AUX-ROSES
NEUROPRION: European network dedicated to research on prion diseases

ILE-DE-FRANCE
PARIS
NEUPROCF: new diagnostic and prognostic biomarkers in cystic fibrosis (FINISHED)

ILE-DE-FRANCE
PARIS
THERAPEUSKIN: European network on gene therapy of hereditary epidermolysis bullosa (FINISHED)

ILE-DE-FRANCE
PARIS
MYASTAID: European network on myasthenia (FINISHED)

ILE-DE-FRANCE
PARIS
EVI-GENORET: functional genomics of the retina in health and disease (FINISHED)

OCCITANIE
MONTPELLIER
GENOSTEM: adult mesenchymal stem cells for connective tissue disorders: from the bench to the bed side (FINISHED)

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE
MPCM: pathogenic role of micro-vesiculation in cerebral malaria (FINISHED)

EMILIA ROMAGNA
BOLOGNA
PROTHETS: prognosis and therapeutic targets in the 'Ewing' family of tumors (FINISHED)

FRIULI VENEZIA GIULIA
AVIANO
VITAL: development of optimised recombinant idiotypic vaccines for subset-specific immunotherapy of B cell lymphomas

LAZIO
ROMA
GENESKIN: European network on rare genetic skin diseases

LOMBARDIA
MILANO
SPASTICMODELS: genetic models of chronic neuronal degeneration causing hereditary spastic paraplegia

TOSCANA
SIENA
TAMAHUD: identification of early disease markers, novel pharmacologically tractable targets and small molecule phenotypic modulators in Huntington's Disease

VENETO
TREVISO
PNSEURONET: European network on Paraneoplastic Neurological Syndromes

Gelderland
NIJMEGEN
EUMITOCOMBAT: rational treatment strategies combating mitochondrial oxidative phosphorylation (OXPHOS) disorders (TERMINATED)

Gelderland
NIJMEGEN
EUROSTEC: soft tissue engineering for congenital birth defects: New treatment modalities for spina bifida, urogenitial and abdominal wall defects (COMPLETED)

Groningen
GRONINGEN
MMR-RELATED CANCER: prevention, diagnosis and molecular characterisation of mismatch repair defect-related hereditary cancers of the digestive system

Limburg
MAASTRICHT
MITOCIRCLE: mitochondrial diseases: from bedside to genome to bedside (FINISHED)

Noord-Holland
AMSTERDAM
ANTEPRION: development of a pre-clinical blood test for prion diseases (COMPLETED)

Zuid-Holland
LEIDEN
EUROBONET: European bone tumors network

WIEN
ADDRESS: NOT PROVIDED - AT
ENRAH-SME: European network for research on alternating hemiplegia in childhood for promoting SMEs integration

WIEN
WIEN
SARS/FLU VACCINE: development of a combined Influenza/SARS vaccine

WIEN
WIEN
PEROXISOMES: Integrated project to decipher the biological function of peroxisomes in health and disease

WIEN
WIEN
EURO-LAMINOPATHIES: nuclear envelope-linked rare human diseases: from molecular pathophysiology towards clinical applications

Cataluña
BARCELONA
EUGINDAT: European genomics initiative on disorders of plasma membrane amino acid transporters

Cataluña
BARCELONA
MALARIA AGE EXPOSURE: age of exposure and immunity to malaria in infants

Avon
BRISTOL
EUROCARE CF: European coordination action for research in cystic fibrosis

Cambridgeshire
CAMBRIDGE
PWS: Prader-Willi Syndrome: a model linking gene expression, obesity and mental health

Cambridgeshire
CAMBRIDGE
EUNEURONE: European Consortium for Research in Neurodegenerative Diseases

Merseyside
LIVERPOOL
ANTIMAL: development of new drugs for the treatment of malaria

South Yorkshire
SHEFFIELD
EUROWILSON: European network on Wilson disease (research)

Tyne & Wear
NEWCASTLE UPON TYNE
TREAT-NMD: Accelerating Treatments for Neuromuscular Diseases (research)

West Yorkshire
LEEDS
GenoMEL : the Melanoma Genetics Consortium

Region Uppsala
UPPSALA
EURAPS: autoimmune polyendocrine syndrome type I - a rare disorder of childhood as a model for autoimmunity (TERMINATED)

Region Uppsala
UPPSALA